Gene · 2810
Papers2,367
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
121 to 140 of 2,367
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Lineage plasticity and treatment resistance in prostate cancer: the intersection of genetics, epigenetics, and evolution. | Front Endocrinol (Lausanne) | 2023 | 37455903 | PubTator, text mining | PubMed |
| Liquid biopsy: an examination of platelet RNA obtained from head and neck squamous cell carcinoma patients for predictive molecular tumor markers. | Explor Target Antitumor Ther | 2023 | 37455825 | PubTator, text mining | PubMed |
| The Hippo Pathway Effectors YAP/TAZ-TEAD Oncoproteins as Emerging Therapeutic Targets in the Tumor Microenvironment. | Cancers (Basel) | 2023 | 37444578 | PubTator, text mining | PubMed |
| Prognostic evaluation of pancreatic cancer based on the model of chemo-radiotherapy resistance-related genes. | J Gastrointest Oncol | 2023 | 37435207 | PubTator, text mining | PubMed |
| Comprehensive analysis of anoikis-related lncRNAs for predicting prognosis and response of immunotherapy in hepatocellular carcinoma. | IET Syst Biol | 2023 | 37417684 | PubTator, text mining | PubMed |
| A model-informed method to retrieve intrinsic from apparent cooperativity and project cellular target occupancy for ternary complex-forming compounds. | RSC Chem Biol | 2023 | 37415863 | PubTator, text mining | PubMed |
| Inhibition of clonal expansion of parietal epithelial cells and crescent-podocyte transition in severe glomerulonephritis: on the way to targeted therapy? | Clin Kidney J | 2023 | 37398681 | PubTator, text mining | PubMed |
| Decoding the lncRNAome Across Diverse Cellular Stresses Reveals Core p53-effector Pan-cancer Suppressive lncRNAs. | Cancer Res Commun | 2023 | 37377895 | PubTator, text mining | PubMed |
| Role of Histone Deacetylases in the Pathogenesis of Salivary Gland Tumors and Therapeutic Targeting Options. | Int J Mol Sci | 2023 | 37373187 | PubTator, text mining | PubMed |
| Loss of PRDX6 Aborts Proliferative and Migratory Signaling in Hepatocarcinoma Cell Lines. | Antioxidants (Basel) | 2023 | 37371884 | PubTator, text mining | PubMed |
| Hericium erinaceus, a medicinal fungus with a centuries-old history: Evidence in gastrointestinal diseases. | World J Gastroenterol | 2023 | 37346156 | PubTator, text mining | PubMed |
| RadWise: A Rank-Based Hybrid Feature Weighting and Selection Method for Proteomic Categorization of Chemoirradiation in Patients with Glioblastoma. | Cancers (Basel) | 2023 | 37345009 | PubTator, text mining | PubMed |
| Structural mapping of PEAK pseudokinase interactions identifies 14-3-3 as a molecular switch for PEAK3 signaling. | Nat Commun | 2023 | 37336884 | PubTator, text mining | PubMed |
| Insights into the Structural Conformations of the Tau Protein in Different Aggregation Status. | Molecules | 2023 | 37299020 | PubTator, text mining | PubMed |
| Plakophilin-3 Binds the Membrane and Filamentous Actin without Bundling F-Actin. | Int J Mol Sci | 2023 | 37298410 | PubTator, text mining | PubMed |
| Effectiveness of Nonfunctionalized Graphene Oxide Nanolayers as Nanomedicine against Colon, Cervical, and Breast Cancer Cells. | Int J Mol Sci | 2023 | 37298090 | PubTator, text mining | PubMed |
| A Comprehensive Transcriptional Signature in Pancreatic Ductal Adenocarcinoma Reveals New Insights into the Immune and Desmoplastic Microenvironments. | Cancers (Basel) | 2023 | 37296850 | PubTator, text mining | PubMed |
| Protein-protein interactions: developing small-molecule inhibitors/stabilizers through covalent strategies. | Trends Pharmacol Sci | 2023 | 37263826 | PubTator, text mining | PubMed |
| Targeting the p53 signaling pathway in cancers: Molecular mechanisms and clinical studies. | MedComm (2020) | 2023 | 37256211 | PubTator, text mining | PubMed |
| A Systematic Approach to the Discovery of Protein-Protein Interaction Stabilizers. | ACS Cent Sci | 2023 | 37252362 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2810/papers?page=7